November 2023
1. GALILEYA LT, Wasmann RE, Chabala C, Rabie H, et al
   Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
   PLoS Med. 2023;20:e1004303.
   

   >> Share

   
   
2. OLSEN A, Beall RF, Knox RP, Tu SS, et al
   Patents and regulatory exclusivities on FDA-approved insulin products: A longitudinal database study, 1986-2019.
   PLoS Med. 2023;20:e1004309.
   

   >> Share

   
   February 2023
3. MATTHEWS LT, Atukunda EC, Owembabazi M, Kalyebera KP, et al
   High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study.
   PLoS Med. 2023;20:e1004088.
   

   >> Share

   
   October 2022
4. LOWE DM, Brown LK, Chowdhury K, Davey S, et al
   Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 x 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
   PLoS Med. 2022;19:e1004120.
   

   >> Share

   
   September 2022
5. TAPSOBA JD, Cover J, Obong'o C, Brady M, et al
   Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study.
   PLoS Med. 2022;19:e1004097.
   

   >> Share

   
   November 2021
6. BULSTRA CA, Hontelez JAC, Otto M, Stepanova A, et al
   Integrating HIV services and other health services: A systematic review and meta-analysis.
   PLoS Med. 2021;18:e1003836.
   

   >> Share

   
   October 2021
7. AMSTUTZ A, Lejone TI, Khesa L, Kopo M, et al
   Offering ART refill through community health workers versus clinic-based follow-up after home-based same-day ART initiation in rural Lesotho: The VIBRA cluster-randomized clinical trial.
   PLoS Med. 2021;18:e1003839.
   

   >> Share

   
   June 2021
8. CELUM C, Hosek S, Tsholwana M, Kassim S, et al
   PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
   PLoS Med. 2021;18:e1003670.
   

   >> Share

   
   February 2021
9. KOSS CA, Havlir DV, Ayieko J, Kwarisiima D, et al
   HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
   PLoS Med. 2021;18:e1003492.
   

   >> Share

   
   November 2020
10. SCULIER D, Wandeler G, Yerly S, Marinosci A, et al
    Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
    PLoS Med. 2020;17:e1003421.
    

    >> Share

    
    September 2020
11. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    

    >> Share

    
    
12. AMSTUTZ A, Nsakala BL, Vanobberghen F, Muhairwe J, et al
    Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    PLoS Med. 2020;17:e1003325.
    

    >> Share

    
    February 2020
13. FORD N, Geng E, Ellman T, Orrell C, et al
    Emerging priorities for HIV service delivery.
    PLoS Med. 2020;17:e1003028.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share